Oncology Network

 

Research in oncology is the area of excellence of the Pierre Fabre Group and its major therapeutic field. Around 50% of R&D investments in the Group's medical product branch are currently devoted to oncology. Two major Research centers of the Pierre Fabre Research Institute are focused on the field of Cancer."

This strong commitment to research in Oncology is also illustrated by Pierre Fabre’s participation in the Oncopole of Toulouse (France), an exceptional campus that gather basic and clinical research, drug and technology development and healthcare.